Microsoft Azure Crosses $100 Billion Milestone With 43% Growth as MSFT Stock Surges
Microsoft delivered a landmark fiscal fourth-quarter earnings report on July 29, announcing that Azure cloud crossed $100 billion in annual revenue for the first time in company history. Azure grew 43% in the quarter — the fastest pace since early 2022 — handily topping the 40% increase analysts had forecast. The result sent Microsoft stock surging, with shares jumping sharply in after-hours trading and extending gains on July 30. The company reported total Q4 revenue of $90 billion, up 18% ...
Read More About This
Read More About This
Meta Beats on Revenue but Free Cash Flow Collapses 91% as AI Spending Hits $31 Billion
Meta Platforms reported Q2 2026 revenue of $60.8 billion on July 29 — a 28% year-over-year gain that topped the Wall Street consensus of $60.2 billion. But the headline number is where the good news ends for bulls. EPS of $6.18 missed the $7.22 estimate by 14%, and free cash flow cratered 91% to just $784 million — down from $8.55 billion in Q2 2025. Meta stock tumbled 9% to 11% in after-hours trading, a sharp reversal from what had ...
Read More About This
Read More About This
Apple Posts Record $109.4B Quarter but Stock Falls 6% on China and Services Miss
Apple delivered its best June quarter ever on July 30, reporting fiscal Q3 2026 revenue of $109.4 billion — up 16% year over year — and earnings per share of $2.02, well above the $1.89 analysts had forecast. Net profit hit $29.8 billion, and total revenue cleared the $108.8 billion consensus estimate. Yet despite the headline beat, Apple stock fell more than 6% in after-hours trading as investors zeroed in on two key misses: Greater China revenue and Services growth.The ...
Read More About This
Read More About This
PCE Inflation Cools to 3.7% in June — But the Fed Is Still Talking Hikes, Not Cuts
The Federal Reserve's preferred inflation gauge cooled meaningfully in June, but the data has done little to change the central bank's hawkish posture. The Bureau of Economic Analysis reported on July 30 that the headline Personal Consumption Expenditures (PCE) price index rose 3.7% year over year in June — a sharp drop from 4.1% in May and the lowest reading in months. Core PCE, which strips out volatile food and energy prices and is the Fed's truest signal for underlying ...
Read More About This
Read More About This
Chip Stocks Stage Historic Comeback: Intel and AMD Surge 13%, SOXX ETF Jumps 8% in One Session
The semiconductor sector staged one of its most dramatic single-session reversals of 2026 on July 30, erasing a significant chunk of the $1 trillion-plus in market value wiped from chip stocks in the prior session. Intel (INTC) and AMD both soared 13% on the day — Intel to $92.67, AMD to $483.55 — while Taiwan Semiconductor Manufacturing (TSM) rallied 7% to $399.36. Lam Research (LRCX), which had reported record fiscal Q4 2026 revenue of $6.72 billion the previous evening, surged ...
Read More About This
Read More About This
Amazon Q2 2026: AWS Hits $42 Billion as AI Business Surpasses $25 Billion Run Rate
Amazon delivered one of its most impressive quarterly performances ever on July 30, 2026, reporting Q2 revenue of $200.6 billion — a 20% year-over-year jump and the company's first quarter above the $200 billion mark. The headline number beat Wall Street's expectations, but the real story was inside Amazon Web Services. AWS revenue surged 37% year over year to $42.2 billion, marking its fastest growth rate in 18 quarters and putting the cloud division on a $169 billion annualized revenue ...
Read More About This
Read More About This
Moderna Has Doubled in 2026 — But Wall Street Is Not Buying the Rally
Moderna (NASDAQ: MRNA) shares have surged more than 100% in 2026, with the stock recently touching 52-week highs above $81 per share. But Wall Street analysts are nowhere close to endorsing the move. The consensus rating on MRNA sits at "Reduce," with an average 12-month price target of around $38 to $49 — roughly 40% to 50% below where the stock is trading today. That disconnect between price performance and analyst conviction makes Moderna one of the most controversial biotech ...
Read More About This
Read More About This
Fed Holds Rates in 9-3 Vote as GDP Slips to 1.5% — A Stagflation Warning Investors Can’t Ignore
The Federal Reserve held its benchmark interest rate steady in a 3.5%–3.75% target range on Wednesday, July 29, but the vote was far from unanimous: three members dissented in favor of a rate hike — the most fractured Fed decision in years. Hours later on Thursday morning, the Bureau of Economic Analysis delivered another blow: Q2 2026 GDP grew at just 1.5% annualized, missing the 2.1% consensus forecast and slowing sharply from 2.1% in Q1. The combination sent the Dow ...
Read More About This
Read More About This